Anavex Life Sciences Corp (AVXL)

[xodcode]

Hard to be too disappointed in a $17 price today, given the 52 week low of $3.75.

No reason to believe that we won't see another 5-fold price increase in the next 12 months, given the solid AVXL that has been meticulously laid under the direction of TGD.

Five years of available cash, no debt, and a massive pipeline built upon a solid foundation of testing and research.

What's not to like?